TransMedics Group, Inc. (TMDX)

Last Closing Price: 131.54 (2025-10-31)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

TransMedics Group, Inc. (TMDX) had Net Income of $24.32M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$143.82M
Net Income
$24.32M
$59.25M
$84.58M
$120.52M
$23.30M
$-0.27M
$23.03M
$23.03M
$24.32M
$24.32M
$24.32M
$24.32M
$23.30M
$30.15M
34.11M
40.75M
$0.71
$0.66
Balance Sheet Financials
$613.00M
$313.02M
$333.04M
$946.03M
$79.72M
$506.69M
$511.11M
$590.83M
$355.20M
$341.65M
$355.20M
34.15M
Cash Flow Statement Financials
$158.33M
$-43.74M
$13.76M
$337.15M
$466.67M
$129.52M
$27.47M
--
--
Fundamental Metrics & Ratios
7.69
--
--
0.59
1.44
58.80%
16.20%
16.20%
--
16.01%
16.91%
$114.59M
--
--
--
0.15
1.33
1.78
50.50
6.85%
7.12%
2.57%
2.82%
$10.40
$2.81
$3.89